201 The
primary end point of the study was 30-day cumulative
incidence of death/stroke/MI, which was 5.4% for
asymptomatic patients who underwent CAS and 10.2%
for CEA (P ¼.20). Critics of this study raised several
important issues, including the criteria used to deﬁne
high-risk patients for CEA, the failure to randomize more
than 50%